RecruitingNot ApplicableNCT06601621

Study on the Impact of Electroacupuncture Combined With Self-Acupressure on the Quality of Life of Patients With Early-Stage Breast Cancer Undergoing Chemotherapy


Sponsor

Jiuda Zhao

Enrollment

192 participants

Start Date

Oct 19, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This randomized controlled clinical trial aims to evaluate the effect of electroacupuncture combined with self-acupressure on the quality of life of early-stage breast cancer patients receiving chemotherapy.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether electroacupuncture (acupuncture with mild electrical stimulation) combined with self-applied acupressure can improve quality of life — including fatigue, nausea, and pain — for women with early-stage breast cancer who are undergoing chemotherapy. **You may be eligible if...** - You are between 18 and 75 years old - You have been diagnosed with early-stage breast cancer - You have not received chemotherapy before and are scheduled to receive at least 4 cycles of chemotherapy (with or without targeted therapy) - Your organ function is within acceptable ranges - Premenopausal women must use appropriate contraception **You may NOT be eligible if...** - You have a fear or allergy to needles or stainless steel - You have a current diagnosis of a serious mental illness (depression, schizophrenia, obsessive-compulsive disorder) - You have an autoimmune disease, blood disorder, or organ transplant history - You have a bleeding disorder, thyroid dysfunction, or a pacemaker - You are pregnant or breastfeeding - You are planning adjuvant radiation during your upcoming chemotherapy cycles - You received acupuncture within the past four weeks Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

COMBINATION_PRODUCTelectroacupuncture+ self-acupressure

Participants will receive two electroacupuncture treatments within the first week of each treatment cycle. The acupuncturist inserts the needle into the point and manipulates the needle until the feeling of "deqi"; is achieved and reported by the participant. The electrical stimulation will be administered at a sustained frequency of 2/10Hz for 30 minutes. self-acupressure: In weeks 2 and 3 of each treatment cycle, participants performed true self-administered acupressure, pressing each acupoint with their thumb to achieve "deqi"; for three minutes.

COMBINATION_PRODUCTsham electroacupuncture + sham self-acupressure

Sham electroacupuncture: The sham electroacupuncture shallow needle insertion using thin and short needles at body locations not recognized as true acupuncture points and are deemed to not belong to traditional Chinese meridians and have no therapeutic value. Participants will receive acupuncture treatment without electrical stimulation same the intervention group. And avoid "deqi"; sensation. Sham self-acupressure: Administered non-acupressure points 1 to 3cm away from the true acupressure points used in the experimental group and away from known meridians. The frequency, course duration, and overall treatment time will be the same as those in the true self-administered shiatsu group. The applied pressure does not cause a feeling of "deqi".


Locations(1)

Qinghai University Affiliated Hospital

Xining, Qinghai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06601621


Related Trials